NCT05353881

Brief Summary

REM sleep behavior disorder is a novel and distinct parasomnia characterized by recurrent dream enactment behaviors (DEBs) and REM sleep without atonia (RSWA) during polysomnographic assessment, with a male predominance and typical onset age at early 60's. The majority of patients with idiopathic RBD (iRBD) will eventually develop α-synucleinopathy, for instance Parkinson's disease (PD). Thus, iRBD has been considered as a highly specific precursor of α-synucleinopathy-related neurodegeneration. Recently, increasing studies have found that some participants present with only RSWA or DEBs (but without sufficient RSWA), which does not meet the diagnostic criteria for RBD. It has been suggested that these participants with subclinical features (either DEBs or RSWA) might represent a condition known as prodromal RBD. Several emerging evidence, including our own study, have implied a link between isolated RSWA (RSWA without DEBs) and markers of α-synucleinopathy-related neurodegeneration. However, it is still unclear whether the other condition related to RBD, i.e. recurrent DEBs but without sufficient RSWA, is related to a certain degree of α-synucleinopathy. In this regard, the novel concept of recurrent DEBs but without sufficient RSWA, also termed as prodromal/isolated RBD by some researchers, requires validation by further evidence in terms of clinical feature and neurodegenerative prodromal markers perspectives.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

January 3, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 29, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

April 19, 2024

Status Verified

April 1, 2024

Enrollment Period

2.5 years

First QC Date

December 21, 2021

Last Update Submit

April 17, 2024

Conditions

Keywords

Striatal dopamineREM sleep without atoniaProdromal markers

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Parkinson's Disease

    overall probability of prodromal PD based on the MDS research criteria for prodromal PD

    1 year

Interventions

No intervention

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The recruiting ability for the current study is further evidenced by a series of studies and publications in the past few years. For example, in our ongoing case-control family study, the investigator have recruited 89 control proband and 64 their FDRs who have all underwent v-PSG (Liu et al, Annals of Neurology 2019). By now, the investigator have expanded the number to 103 control probands and 91 FDRs. The investigator believe that this cohort will help us to recruit sufficient number of control subjects in this proposed study.

You may qualify if:

  • Age between 45 and 65 years old
  • RBDQ-HK behavior factor greater \> 8
  • Recurrent DEBs by interview and/or video analysis
  • Absence of sufficient RSWA

You may not qualify if:

  • Age- and sex- matched with cases
  • RBDQ-HK behavior factor \< 8
  • No DEBs by either interview or video analysis
  • Absence of sufficient RSWA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shatin Hospital

Shatin, Hong Kong

RECRUITING

MeSH Terms

Conditions

REM Sleep Behavior Disorder

Condition Hierarchy (Ancestors)

REM Sleep ParasomniasParasomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Yun Kwok Wing, Professor

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 21, 2021

First Posted

April 29, 2022

Study Start

January 3, 2022

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

April 19, 2024

Record last verified: 2024-04

Locations